Canal Insurance Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-150
Closed -$204K 82
2024
Q3
$204K Buy
+150
New +$28K 0.05% 82
2023
Q2
Sell
-225
Closed -$153K 91
2023
Q1
$153K Sell
225
-25
-10% -$3.82K 0.04% 85
2022
Q4
$440K Buy
+250
New +$38.3K 0.12% 73
2022
Q2
Sell
-100
Closed -$105K 101
2022
Q1
$105K Sell
100
-100
-50% -$14.5K 0.03% 80
2021
Q4
$410K Buy
+200
New +$23.6K 0.12% 68
2021
Q3
Sell
-200
Closed -$43K 78
2021
Q2
$43K Hold
200
0.02% 71
2021
Q1
$34K Sell
200
-19,800
-99% -$2.12M 0.01% 59
2020
Q4
$53K Hold
20,000
0.02% 61
2020
Q3
$8K Hold
20,000
﹤0.01% 68
2020
Q2
$86K Sell
20,000
-10,000
-33% -$880K 0.03% 61
2020
Q1
$8K Buy
+30,000
New +$2.56M ﹤0.01% 67
2019
Q3
Sell
-30,000
Closed -$12K 64
2019
Q2
$12K Hold
30,000
﹤0.01% 68
2019
Q1
$53K Hold
30,000
0.02% 67
2018
Q4
$43K Hold
30,000
0.02% 59
2018
Q3
$44K Buy
+30,000
New +$2.84M 0.01% 69
2016
Q2
Sell
-25,000
Closed -$83K 99
2016
Q1
$83K Buy
+25,000
New +$1.39M 0.03% 90
2015
Q3
Sell
-16,000
Closed -$49K 92
2015
Q2
$49K Buy
+16,000
New +$1.04M 0.02% 82

Other funds holding ABBV

Canal Insurance Company's ABBV Position: Q2 2026 in Review

Canal Insurance Company held its AbbVie (ABBV) position steady in Q2 2026 at 92,500 shares worth $23.3M. The position accounts for 5.1% of the portfolio, ranked #2.

Canal Insurance Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Canal Insurance Company held 92,500 shares of AbbVie worth $23.3M as of Q2 2026.
  • Canal Insurance Company left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 5.1% of Canal Insurance Company's portfolio in Q2 2026, its #2 holding.
  • Canal Insurance Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.